If the cells you would like to access are currently listed as unavailable or you are ordering from outside of Europe please get in touch via Contact@EBiSC.org.

WTSIi006-A

HPSI1113i-hayt_1

iPSC line

Not-for-profit fee: £1400 per vial
Immediately available for distribution*
*Once all legal and processing details completed
A CLIP contains information about a cell line including any specific third party obligations relating to, for example, licensing obligations or the donor consent which affect the use of the cell line.

The EBiSC Access and Use Agreement must be completed along with an individual Cell Line Information Pack for each line. Complete the EAUA and send to Contact@EBiSC.org for countersignature. The EAUA must be fully signed before proceeding with your order.
A batch specific Certificate of Analysis will be available to download once you receive your EBiSC iPSC line.

General#

Cell Line

hPSCreg name WTSIi006-A
Alternative name(s)
HPSI1113i-hayt_1
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
WTSIi006-B
(HPSI1113i-hayt_3)

Provider

Depositor Wellcome Sanger Institute (WTSI)
Distributors
EBiSC
Derivation country United Kingdom

External Databases

hPSCreg WTSIi006-A
BioSamples SAMEA2445790
HipSci HPSI1113i-hayt_1
Cellosaurus CVCL_AE23
Wikidata Q54891631

General Information

Publications View all related publications on hPSCreg (1)
This EBiSC line can be used for:
Yes
Research use: allowed
Clinical use: no
Commercial use: no

Donor Information#

General Donor Information

Sex male
Age of donor (at collection) 70-74
Ethnicity White - Other

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA2398697
HipSci HPSI-hayt

hIPSC Derivation#

General

Source cell type
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.; These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.
Source cell origin
Any portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
Synonyms
  • portion of skin
  • region of skin
  • skin
  • skin region
  • skin zone
show more synonyms
Age of donor (at collection) 70-74
Collected in 2014
Source cell line vendor Cambridge BioResource

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Notes on reprogramming vector detection CytoTune 1

Vector free reprogramming

Other

Selection criteria for clones Morphology
Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions#

Latest released batch

Culture medium Essential E8
Passage method EDTA
Surface coating Vitronectin
O2 concentration 21
CO2 concentration 5
Temperature 37
The following are the depositor culture conditions, they do not refer to any specific batch.
Surface coating Vitronectin
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
CO2 Concentration 5 %
Medium TeSR™ E8™

Characterisation#

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
SOX2
Yes
NANOG
Yes
TRA 1-60
Yes
SSEA-4
Yes
SSEA-1
No
Pluripotency Score Novelty Score Link to microarray data
22.113 1.264 http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4057/

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Sterility

Inoculation for microbiological growth No Contaminants Detected
Mycoplasma Not Detected
Viability Viable post-cryopreservation

Genotyping#

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
No

Other Genotyping (Cell Line)

Is there genome-wide genotyping or functional data available?
Yes
cnv
http://www.hipsci.org/lines/#/lines/HPSI1113i-hayt_1
Number of regions different from primary tissue: 0; Length of differences from primary tissue: 0
RNA-seq
http://www.ebi.ac.uk/ena/data/view/ERR914310
Raw sequencing reads
RNA-seq
http://www.ebi.ac.uk/ena/data/view/ERR914346
Raw sequencing reads
Methylation profiling
http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4059/
Text file with probe intensities
Exome sequencing
http://www.ebi.ac.uk/ena/data/view/ERZ122973
Imputed and phased genotypes
RNA-seq
http://www.ebi.ac.uk/ena/data/view/ERZ267017
Abundances of transcripts
Genotyping array
http://www.ebi.ac.uk/ena/data/view/ERZ127577
Genotyping array calls
Exome sequencing
http://www.ebi.ac.uk/ena/data/view/ERR947048
Raw sequencing reads
Genotyping array
http://www.ebi.ac.uk/ena/data/view/ERZ127342
Imputed and phased genotypes
Whole genome sequencing
http://www.ebi.ac.uk/ena/data/view/ERR1861329
Raw sequencing reads
Whole genome sequencing
http://www.ebi.ac.uk/ena/data/view/ERZ448050
GATK haplotype calls
RNA-seq
http://www.ebi.ac.uk/ena/data/view/ERZ123040
Splice-aware STAR alignment
Exome sequencing
http://www.ebi.ac.uk/ena/data/view/ERZ122907
mpileup variant calls
Exome sequencing
http://www.ebi.ac.uk/ena/data/view/ERR947040
Raw sequencing reads
WGS-derived disease associations
3-hydroxyisobutyryl-CoA hydrolase deficiency (HIBCH)
arrhythmogenic right ventricular cardiomyopathy (MYH7)
autosomal recessive limb-girdle muscular dystrophy (SGCA)
Charcot-Marie-Tooth disease (FIG4, HINT1)
Cohen syndrome (VPS13B)
collagen 6-related myopathy (COL6A2)
complex neurodevelopmental disorder (CNTNAP2, SETBP1)
demyelinating hereditary motor and sensory neuropathy (MTMR2)
dilated cardiomyopathy (MYH7)
factor XIII, b subunit, deficiency of (F13B)
Fanconi anemia complementation group A (FANCA)
focal segmental glomerulosclerosis 9 (CRB2)
hypertrophic cardiomyopathy (MYH7)
Leigh syndrome (HIBCH)
Lynch syndrome (PMS1)
mitochondrial disease (NDUFS6)
monogenic diabetes (PAX4)
mucopolysaccharidosis type 1 (IDUA)
mucopolysaccharidosis type 4A (GALNS)
MYH7-related skeletal myopathy (MYH7)
nephronophthisis 4 (NPHP4)
nonsyndromic genetic hearing loss (CDH23, MYO7A, TMPRSS3)
PHARC syndrome (ABHD12)
primary ciliary dyskinesia 2 (DNAAF3)
primary ciliary dyskinesia 5 (HYDIN)
primary ciliary dyskinesia 7 (DNAH11)
PTEN hamartoma tumor syndrome (PTEN)
renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (ATP6V1B1)
Rothmund-Thomson syndrome (RECQL4)
Schinzel-Giedion syndrome (SETBP1)
syndromic intellectual disability (KMT2C)
turnpenny-fry syndrome (PCGF2)
Usher syndrome type 1 (CDH23, MYO7A)
vitamin K-dependent clotting factors, combined deficiency of, type 2 (VKORC1)
Other WGS-derived genes
AGAP6, AGL, ALDH3A2, ANAPC1, AURKC, BMP4, CASP12, COLQ, CYP21A2, CYP2D6, CYP2F1, CYP3A5, D2HGDH, DEFB126, DNAAF1, DSC3, ERCC6L2, FANCM, FBXO7, FCGR2A, FLG2, FUT2, GLYCTK, GPRIN1, HSD17B13, IDO2, IRF5, ITGB2, KCNJ16, KCNMB3, KLRC3, LAMA5, LPL, MICA, MROH8, NDUFB9, NFU1, OAS1, OPRM1, OR1B1, OR52B4, P2RX5, PDE4DIP, PIGN, POLDIP2, POLR3B, PYGL, RP1L1, RXFP2, SELPLG, SIGLEC12, SLC37A4, SRA1, SYNE2, TBP, TGIF1, TIGD6, TMEM107, TMEM175, TMEM216, TMPRSS6, TMX3, TNRC18, TREH, TRPM1, UTRN, VDR, WDR37, ZNF83